ATOSIBAN: 601 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
601
Total FAERS Reports
18 (3.0%)
Deaths Reported
108
Hospitalizations
601
As Primary/Secondary Suspect
20
Life-Threatening
First Report: 20100501 · Latest Report: 20241205
What Are the Most Common ATOSIBAN Side Effects?
#1 Most Reported
Maternal exposure during pregnancy
299 reports (49.8%)
#2 Most Reported
Premature baby
246 reports (40.9%)
#3 Most Reported
Premature delivery
232 reports (38.6%)
All ATOSIBAN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Maternal exposure during pregnancy | 299 | 49.8% | 2 | 26 |
| Premature baby | 246 | 40.9% | 12 | 43 |
| Premature delivery | 232 | 38.6% | 0 | 10 |
| Foetal exposure during pregnancy | 219 | 36.4% | 15 | 47 |
| Product use in unapproved indication | 177 | 29.5% | 0 | 1 |
| Delivery | 123 | 20.5% | 0 | 0 |
| Normal labour | 123 | 20.5% | 0 | 0 |
| Low birth weight baby | 52 | 8.7% | 4 | 27 |
| Exposure during pregnancy | 50 | 8.3% | 1 | 18 |
| Acute pulmonary oedema | 22 | 3.7% | 0 | 15 |
| Drug ineffective | 22 | 3.7% | 4 | 5 |
| Off label use | 16 | 2.7% | 3 | 7 |
| Neonatal respiratory distress syndrome | 15 | 2.5% | 0 | 9 |
| Condition aggravated | 14 | 2.3% | 6 | 5 |
| Dyspnoea | 13 | 2.2% | 0 | 10 |
| Inguinal hernia | 13 | 2.2% | 0 | 13 |
| Pleural effusion | 13 | 2.2% | 0 | 12 |
| Anaemia | 12 | 2.0% | 0 | 10 |
| Foetal distress syndrome | 12 | 2.0% | 0 | 9 |
| Hyperbilirubinaemia | 12 | 2.0% | 0 | 11 |
Who Reports ATOSIBAN Side Effects? Age & Gender Data
Gender: 92.2% female, 7.8% male. Average age: 31.5 years. Most reports from: CA. View detailed demographics →
Is ATOSIBAN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 4 | 1 | 2 |
| 2011 | 4 | 0 | 3 |
| 2012 | 1 | 0 | 0 |
| 2015 | 4 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 9 | 0 | 8 |
| 2018 | 3 | 0 | 1 |
| 2019 | 1 | 0 | 0 |
| 2020 | 8 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 3 | 0 | 3 |
| 2023 | 8 | 0 | 0 |
| 2024 | 1 | 0 | 1 |
What Is ATOSIBAN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 236 |
| Foetal exposure during pregnancy | 117 |
| Tocolysis | 70 |
| Threatened labour | 25 |
| Uterine contractions during pregnancy | 17 |
| Premature labour | 14 |
| Prophylaxis | 7 |
| Exposure during pregnancy | 6 |
| Premature delivery | 5 |
ATOSIBAN vs Alternatives: Which Is Safer?
ATOSIBAN vs ATOVAQUONE
ATOSIBAN vs ATOVAQUONE\PROGUANIL
ATOSIBAN vs ATRACURIUM
ATOSIBAN vs ATRIPLA
ATOSIBAN vs ATROPINE
ATOSIBAN vs ATROPINE\ATROPINE
ATOSIBAN vs ATROPINE\DIPHENOXYLATE
ATOSIBAN vs AUBAGIO
ATOSIBAN vs AUGMENTIN
ATOSIBAN vs AUTOLOGOUS CULTURED CHONDROCYTES
Official FDA Label for ATOSIBAN
Official prescribing information from the FDA-approved drug label.